4//SEC Filing
Weber Barbara 4
Accession 0001610717-24-000504
CIK 0001628171other
Filed
Oct 9, 8:00 PM ET
Accepted
Oct 10, 4:16 PM ET
Size
5.0 KB
Accession
0001610717-24-000504
Insider Transaction Report
Form 4
Weber Barbara
Director
Transactions
- Sale
Common Stock
2024-10-08$48.02/sh−5,200$249,716→ 13,065 total
Footnotes (3)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 29, 2024.
- [F2]The transaction was executed in multiple trades in prices ranging from $48.00 to $48.08, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Includes 4,248 restricted stock units.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001800670
Filing Metadata
- Form type
- 4
- Filed
- Oct 9, 8:00 PM ET
- Accepted
- Oct 10, 4:16 PM ET
- Size
- 5.0 KB